Major african study tests Mix-and-Match COVID boosters for all
NCT ID NCT07408297
First seen Feb 15, 2026 · Last updated May 20, 2026 · Updated 11 times
Summary
This study tested the safety and immune response of different COVID-19 booster vaccines in about 1,900 adolescents and adults aged 12 to 64 in Kenya, Democratic Republic of Congo, and Rwanda. It included people with and without HIV to see how well the vaccines work in these groups. The goal was to find safe and effective booster options that can be used flexibly in areas with limited vaccine supply.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Victoria Biomedical Research Institute
Kisumu, Kenya
Conditions
Explore the condition pages connected to this study.